Background Adverse events following mRNA COVID-19 vaccines, including herpes zoster
(HZ), have been reported. We conducted a cohort study to evaluate the association between …

Abstract Coronavirus disease 2019 (COVID-19) has had a broad impact on health services
and health outcomes. During the pandemic, there were numerous reports of herpes zoster …

The effect of anemia on the post‐acute outcome of patients with severe acute respiratory
syndrome coronavirus 2 infection was unclear. This study aimed to investigate the potential …

Background There is evidence that SARS-CoV2 infection can increase the risk of herpes
zoster (HZ) in the general population. However, the risk in patients with inflammatory bowel …

Objectives This study aimed to investigate the association between vitamin D deficiency
(VDD) and post-acute outcomes of severe acute respiratory syndrome coronavirus 2 (SARS …

This study was aimed at investigating the risk of cytomegalovirus (CMV) disease among
coronavirus disease 2019 (COVID‐19) survivors. In this retrospective cohort study, we used …

Objectives This study examined the effectiveness of nirmatrelvir plus ritonavir (NMV-r) and
molnupiravir (MOV) in treating COVID-19 among chronic kidney disease (CKD) patients …

Objectives This study investigated the outcomes of underweight patients with COVID-19 and
the effectiveness of antiviral agents in this population. Methods A retrospective cohort study …

Abstract Herpes (varicella) zoster (HZ) infection occurs in 4 people per 1000 in the general
US population (irrespective of prior varicella infection and vaccination status) each year and …

Objectives We aimed to compare the risk of herpes zoster (HZ) in adults with and without
laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …